Vizilex 133mg/58mg Tablet CR

Produktübersicht

About Vizilex 133mg/58mg Tablet CR

Vizilex 133mg/58mg Tablet CR is a controlled‑release formulation that delivers a combined dose of sodium valproate and valproic acid. The tablet is designed to provide a steady release of the active ingredients over an extended period, helping to maintain therapeutic blood levels while reducing the frequency of dosing. It is commonly prescribed for the management of seizure disorders and for the prevention of migraine headaches. The controlled‑release technology allows patients to take the medication once daily, which can improve adherence and overall treatment effectiveness. Each tablet contains 133 mg of sodium valproate and 58 mg of valproic acid, which work together to stabilize neuronal activity and reduce the likelihood of seizure episodes or migraine attacks.

Key Benefits & Uses

• Provides a steady, controlled release of active ingredients for consistent therapeutic effect.
• Reduces dosing frequency to once daily, improving patient compliance.
• Used in the treatment of epilepsy and the prevention of migraine headaches.

Active Ingredient & Action

The active components, sodium valproate and valproic acid, function by increasing the concentration of gamma‑aminobutyric acid (GABA) in the brain, which has an inhibitory effect on neuronal firing. This mechanism helps to stabilize electrical activity in the nervous system, thereby reducing the occurrence of seizures and mitigating migraine pain pathways. The controlled‑release formulation ensures a gradual release of the drug, maintaining effective plasma concentrations over a 24‑hour period.

Important Notes

Patients should follow the prescribing information and consult their healthcare provider before starting or changing therapy. The medication may interact with other drugs and should be taken with caution in patients with liver impairment or a history of gastrointestinal bleeding. Regular monitoring of liver function and blood counts is recommended during long‑term use. Discontinue use if severe side effects occur and seek medical advice promptly.